Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Varagona

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Immunology|July 1, 1995
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?F Puppo, A Picciotto, S Brenci, et al.
Journal of Hepatology|November 1, 1996
Dorfman-Chanarin syndrome: a case with prevalent hepatic involvementD Mela, A Artom, R Goretti, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1993
Long term therapy with recombinant interferon alpha 2 b in patients with chronic hepatitis C: effects on thyroid function and autoantibodiesT Barreca, A Picciotto, R Franceschini, et al.
The Italian Journal of Gastroenterology|December 1, 1994
Biochemical scores could reflect histological activity in chronic hepatitis CR Testa, A Picciotto, G Lapertosa, et al.
Liver|February 1, 1995
Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different dosesA Picciotto, F Callea, G Varagona, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patientsA Picciotto, G Varagona, G Gurreri, et al.
European Journal of Gastroenterology & Hepatology|July 27, 1999
Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to useA Picciotto, N Campo, R Brizzolara, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Immunology|July 1, 1995
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?F Puppo, A Picciotto, S Brenci, et al.
Journal of Hepatology|November 1, 1996
Dorfman-Chanarin syndrome: a case with prevalent hepatic involvementD Mela, A Artom, R Goretti, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1993
Long term therapy with recombinant interferon alpha 2 b in patients with chronic hepatitis C: effects on thyroid function and autoantibodiesT Barreca, A Picciotto, R Franceschini, et al.
The Italian Journal of Gastroenterology|December 1, 1994
Biochemical scores could reflect histological activity in chronic hepatitis CR Testa, A Picciotto, G Lapertosa, et al.
Liver|February 1, 1995
Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different dosesA Picciotto, F Callea, G Varagona, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patientsA Picciotto, G Varagona, G Gurreri, et al.
European Journal of Gastroenterology & Hepatology|July 27, 1999
Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to useA Picciotto, N Campo, R Brizzolara, et al.
Pageof 2